CSI Market
Sign In | Register

Aikido Pharma Inc (DOMH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access DOMH Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Aikido Pharma Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-57.34
Depreciation & amortization0.03
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation19.24
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Fair Value Adjustment Of Warrant Liabilities-
Amortization Of Patents-
Trade And Other Receivables-
Allocated Share Based Compensation Expense Net Of Tax-
Issuance Of Common Stock For Contractual Dispute Settlement Amount-
Noncash Registration Rights Penalty-
Retirement Of Treasury Stock-
Conversion Of Preferred Stock To Common Stock-
Extinguishment Of Series I Convertible Preferred Stock In Connection With License Agreement-
Fair Value Adjustments For Warrant Liabilities-
Marketable Securities Realized Gain Loss-
Change In Fair Value Of Investments-
Amortization Of Rightofuse Assets-
Change In Fair Value Of Shortterm Investment-
Change In Fair Value Of Longterm Investment-
Operating Lease Right Of Use Asset Amortization Expense0.14
Marketable Securities Unrealized Gain Loss0.12
Change In Carrying Value Of Longterm Equity Investments-
Noncash Underwriting Revenue-10.08
Noncash Commissions Expense7.61
Stockbased Compensation Advisors0.04
Income taxes12.86
Losses/ -gains on Investments net8.48
Increase (Decrease) in Receivables from Brokers-Dealers and Clearing Organizations-17.89
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.00
Increase (Decrease) in Accrued Liabilities0.17
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.54
Other Working Capital-0.17
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities7.33
Discontinued operations0.00
Net Cash flow from Operating Activities-28.94
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities41.74
Short-term Investments Acq.-10.85
Real Estate Investments0.00
Purchase Of Fixed Assets-
Payment Of Accrued Patent Costs-
Release Of Deposit-
Proceeds From Sale Of Common Stock-
Unpaid Investment-
Proceeds From Sale Of Digital Currencies-
Proceed From Funds To Deposit Accounts Net-
Purchase Of Shortterm And Longterm Promissory Notes-
Purchase Of Marketable Securities-
Proceeds From Sale Of D at Ch at Common Shares-
Acquisition Of F P S Net Of Cash Acquired And Receivable Owed From F P S-
Purchase Of Shortterm And Longterm Investments-0.10
Proceeds from Collection of Loans To Employees0.10
Restricted Cash and Investments Increase (Decrease)0.00
Payments to Acquire Loans Receivable0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net1.24
Discontinued operations0.00
Net Cash Flow from Investing Activities32.12
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.32
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-0.06
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments For Reverse Stock Split Fractional Shares Payment-
Reverse Stock Split Fractional Share Payment-
Issuance Of Series E Preferred Stock For Cash Net-
Issuance Of Series F Preferred Stock For Cash Net-
Redemption Of Redeemable Series I-
Redemption Of Redeemable Series I Preferred Stock-
Payments For Cancellation Of Common Stock-
Cash Paid For Cancellation Of Fractional Shares Of Common Stock-
Cash Paid For Cancellation Of Common Stock-
Gross Proceeds From Issuance Of Common Stock-
Offering Costs Fro Issuance Of Common Stock Atthemarket Offering-
Proceeds From Issuance Common Stock Common Warrants And Prefunded Warrants Net Of Offering Cost-
Proceeds From Issuance Common Stock Atthemarket Offering-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-9.97
Net Cash Flow from Financing Activities-9.71
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-28.94
Total Cash Flow-6.53
4 historic quarters locked

Sign in to unlock the full Aikido Pharma Inc cash flow history.

Sign In Create Free Account

About Dominari Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-026832

Figures are derived from filed reports and may be restated. Historical data is subject to revision.